Literature DB >> 29966625

Pulmonary Arterial Hypertension.

Mark W Dodson1, Lynette M Brown2, Charles Gregory Elliott3.   

Abstract

This article provides an overview of pulmonary arterial hypertension (PAH), beginning with the initial pathologic recognition of pulmonary hypertension more than 100 years ago and progressing to the current diagnostic categorization of PAH. It reviews the epidemiology, pathophysiology, genetics, and modern treatment of PAH. The article discusses several important recent studies that have highlighted the importance of new management strategies, including serial risk assessment and combination pharmacotherapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMPR2; Endothelin receptor antagonists; Phosphodiesterase-5 inhibitors; Prostacyclin; Pulmonary arterial hypertension; Pulmonary hypertension; REVEAL Registry

Mesh：

Substances：

Year:  2018        PMID： 29966625     DOI： 10.1016/j.hfc.2018.02.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  16 in total

Review 1.  The enzymatic function of the honorary enzyme: S-nitrosylation of hemoglobin in physiology and medicine.

Authors:  Richard T Premont; David J Singel; Jonathan S Stamler
Journal:  Mol Aspects Med       Date:  2021-11-28

Review 2.  Right ventricular failure: a comorbidity or a clinical emergency?

Authors:  Pamelika Das; Rajarajan A Thandavarayan; Kenichi Watanabe; Ravichandiran Velayutham; Somasundaram Arumugam
Journal:  Heart Fail Rev       Date:  2021-11-26       Impact factor: 4.654

Review 3.  Recognizing genetic disease: A key aspect of pediatric pulmonary care.

Authors:  Lael M Yonker; Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane
Journal:  Pediatr Pulmonol       Date:  2020-07

4.  Pulmonary Arterial Hypertension and Therapeutic Interventions.

Authors:  Nader B Ishak Gabra; Omar Mahmoud; Oki Ishikawa; Varun Shah; Erica Altshul; Maly Oron; Bushra Mina
Journal:  Int J Angiol       Date:  2019-06-28

5.  Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice.

Authors:  J Moreno; D Escobedo; C Calhoun; C Jourdan Le Saux; H C Han
Journal:  Exp Mech       Date:  2020-10-14       Impact factor: 2.808

6.  Bilateral lung transplantation after caesarean section in pregnancy with severe pulmonary arterial hypertension: A case report.

Authors:  Jia Ye; Jing-Yu Chen; Na Xu; Bo Wu; Zhi-Ping Wang; Hong-Yang Xu; Jin-Qi Ma
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Targeting JP2: A New Treatment for Pulmonary Hypertension.

Authors:  Rubin Tan; Cui Li; Chuan Xu; Qi Wu; Liping Gao; Yue Shi; Jie Cui
Journal:  Oxid Med Cell Longev       Date:  2021-08-06       Impact factor: 6.543

8.  Increased Smooth Muscle Kv11.1 Channel Expression in Pulmonary Hypertension and Protective Role of Kv11.1 Channel Blocker Dofetilide.

Authors:  Nataliia V Shults; Vladyslava Rybka; Yuichiro J Suzuki; Tinatin I Brelidze
Journal:  Am J Pathol       Date:  2019-12-12       Impact factor: 4.307

9.  TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.

Authors:  Zhi Hu; Qiang Song; Hui Ma; Yaozhang Guo; Tingting Zhang; Hang Xie; Xiaohui Luo
Journal:  J Bioenerg Biomembr       Date:  2021-03-10       Impact factor: 2.945

10.  Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).

Authors:  Alexandra Arvanitaki; Maria Boutsikou; Anastasia Anthi; Sotiria Apostolopoulou; Aikaterini Avgeropoulou; Eftychia Demerouti; Dimitrios Farmakis; Christos Feloukidis; George Giannakoulas; Haralambos Karvounis; Panagiotis Karyofyllis; Ioanna Mitrouska; Sophia Mouratoglou; Katerina K Naka; Stylianos E Orfanos; Evangelia Panagiotidou; Georgia Pitsiou; Spyridon Rammos; Eleni Stagaki; Ioannis Stanopoulos; Adina Thomaidi; Helen Triantafyllidi; Iraklis Tsangaris; Dimitrios Tsiapras; Vassilios Voudris; Athanasios Manginas
Journal:  Pulm Circ       Date:  2019-10-14       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.